Tianwei Xu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 2
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 5
- RNA Research and Splicing 2
-
- Lung Cancer Research Studies 2
-
- Lung Cancer Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
- Journals
- Clinical Cancer Research (1 paper)Molecular Cancer (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Tianwei Xu
15 papers receiving 590 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 399
- Molecular Biology 480
- Clinical Biochemistry 26
- Oncology 72
- Immunology 49
Countries citing papers authored by Tianwei Xu
This map shows the geographic impact of Tianwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianwei Xu more than expected).
Fields of papers citing papers by Tianwei Xu
This network shows the impact of papers produced by Tianwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianwei Xu. The network helps show where Tianwei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tianwei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2023 | 38 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 35 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 92 | |
| 10 | 2020 | 28 | |
| 11 | 2020 | 30 | |
| 12 | 2019 | 49 | |
| 13 | 2018 | 183 | |
| 14 | 2018 | 28 | |
| 15 | 2018 | 0 | |
| 16 | 2018 | 68 |
About Tianwei Xu
Tianwei Xu is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 16 papers that have together received 597 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (2 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), RNA Research and Splicing (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Cancer Research (399 citations), Molecular Biology (480 citations) and Clinical Biochemistry (26 citations). Tianwei Xu has collaborated with scholars based in China and United States. Frequent co-authors include Zhaoxia Wang, Lihua Jiang, Chenchen Wei, Qinnan Chen, Shuai Yan, Shanxun Yu, Pei Ma, Mengwei Wang, Tianyao Lei and Zhenyao Chen. Their work appears in journals such as Clinical Cancer Research, Molecular Cancer and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.